Plus therapeutics to receive $4.6mm reimbursement payment

Austin, texas, sept. 23, 2019 (globe newswire) -- plus therapeutics, inc. (nasdaq: pstv ) (the “company”) today announced that it received notice from the u.s. department of health and human services / office of the assistant secretary for preparedness and response / biomedical advanced research and development authority (“barda”) that, based on retrospective changes in indirect cost rates under contract hhso100201200008c dated september 27, 2012, as amended, barda has agreed to pay the company approximately $4.6 million to reimburse the company for work performed during fiscal years 2012 through 2019.  the company expects to receive such payment from barda in october 2019.
pstv Ratings Summary
pstv Quant Ranking